Devicor® Medical Products, Inc., is a global medical products company dedicated to the investment in, and development of, technologies that facilitate minimally invasive medical procedures. We continuously work to elevate the standard of care and service for our customers and the patients they serve.
We believe the need for superior medical products and technologies that provide patients with the best treatment – more accurately, less invasively, and with shorter recovery times – will continue to grow.
To meet rising demand, Devicor is dedicated to becoming an international leader in the global medical products industry, and aims to achieve this goal by: developing a portfolio of leading brands that are well-known and respected; investing the human and financial resources necessary to help those brands achieve their full growth potential; and embracing a corporate culture that fosters innovation and the entrepreneurial spirit.
In 2008, Devicor was formed with financial backing from GTCR Golder Rauner, LLC, the Chicago‐based private equity firm that pioneered the strategy of identifying and partnering with exceptional executives to build companies through a combination of acquisitions and strong internal growth. GTCR is well-known for long-term partnerships with outstanding management teams, particularly in the areas of healthcare, technology, and consumer products.
Tom Daulton's executive-level global healthcare experience spans two decades and encompasses a variety of senior positions held at Cardinal Health, Allegiance Healthcare and Baxter Healthcare. As CEO of Devicor, he brings a wealth of knowledge in sales and marketing, manufacturing, distribution, business development and management.